Enhanced vs Conventional Recovery After Breast Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-10

Study Completion Date

2024-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the investigators hypothesize that with the use of enhanced recovery of surgery (ERAS), the postoperative hospital stay after breast surgeries is reduced and also postoperative complications are decreased.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ERAS Protocols in Breast Conserving Surgery

NCT06938581

Breast Cancer Postoperative Recovery

RECRUITING NA

Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP)

NCT05363189

Breast Reconstruction Breast Cancer

RECRUITING

Pectoral Nerve Block During Mastectomy

NCT05699902

Breast Cancer Female Pain, Postoperative

UNKNOWN NA

Efficacy of Enhanced Recovery After Surgery Pathway for Total Mastectomy

NCT03181139

Mastectomy Breast Cancer Female

COMPLETED

Effect of Seated Exercises and Psychoeducational Rehabilitation on Fatigue and Coping of Women Postmastectomy

NCT06360276

Fatigue Coping Behavior

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Group A NON-ERAS pathway All patients received best of care practice, with standardization of preoperative and postoperative care. Group B ERAS pathway

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Satisfaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

NON-ERAS pathway All patients received best of care practice, with standardization of preoperative and postoperative care

Group Type ACTIVE_COMPARATOR

NON-ERAS pathway

Intervention Type OTHER

All patients received best of care practice, with standardization of preoperative and postoperative care

Group B

ERAS pathway ERAS consist of approximately 15 elements (or components) that include preoperative, intraoperative, and postoperative interventions .

Group Type ACTIVE_COMPARATOR

ERAS pathway

Intervention Type OTHER

ERAS pathway ERAS consist of approximately 15 elements (or components) that include preoperative, intraoperative, and postoperative interventions .

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NON-ERAS pathway

All patients received best of care practice, with standardization of preoperative and postoperative care

Intervention Type OTHER

ERAS pathway

ERAS pathway ERAS consist of approximately 15 elements (or components) that include preoperative, intraoperative, and postoperative interventions .

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Age: 20-60 years.

* Adequate cognitive state (able to understand and collaborate)
* American society of anesthesia (ASA) I, II

Exclusion Criteria

* Patients who are:

* Uncooperative.
* Having allergy to any of the study drugs.
* Known abuse of alcohol or medication.
* Having Local infection at the site of injection or systemic infection.
* Pregnancy.
* With coagulation disorders.
* Any complicated patients

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes